Gemphire Therapeutics Inc (GEMP) Stock Price, Quote, News and Overview
NASDAQ:GEMP - Nasdaq -
GEMP Quote, Performance and Key Statistics
0.3
0 (-0.37%)
The current stock price of GEMP is 0.3 null. In the past month the price decreased by -16.43%. In the past year, price decreased by -64.07%.
About GEMP
Company Profile
Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company's product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies. Gemphire Therapeutics Inc. is headquartered in Northville, Michigan.
Company Info
Gemphire Therapeutics Inc
17199 N. LAUREL PARK DRIVE SUITE 401
LIVONIA MI 48152
CEO: Steven Gullans
Phone: 734-245-1700
Gemphire Therapeutics Inc / GEMP FAQ
What is the stock price of Gemphire Therapeutics Inc today?
The current stock price of GEMP is 0.3 null. The price decreased by -0.37% in the last trading session.
What is the ticker symbol for Gemphire Therapeutics Inc stock?
The exchange symbol of Gemphire Therapeutics Inc is GEMP and it is listed on the Nasdaq exchange.
On which exchange is GEMP stock listed?
GEMP stock is listed on the Nasdaq exchange.
What is Gemphire Therapeutics Inc worth?
Gemphire Therapeutics Inc (GEMP) has a market capitalization of 4.46M null. This makes GEMP a Nano Cap stock.
What are the support and resistance levels for Gemphire Therapeutics Inc (GEMP) stock?
Gemphire Therapeutics Inc (GEMP) has a resistance level at 0.31. Check the full technical report for a detailed analysis of GEMP support and resistance levels.
Should I buy Gemphire Therapeutics Inc (GEMP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GEMP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GEMP, evaluating the profitability, health, valuation and growth aspects
- Gemphire Therapeutics Inc (GEMP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Gemphire Therapeutics Inc (GEMP) Sales and EPS estimates to see what analysts future expectations are.
- Gemphire Therapeutics Inc (GEMP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Gemphire Therapeutics Inc (GEMP) Insider and Institutional Ownership to learn about the owners and their transactions.
- Gemphire Therapeutics Inc (GEMP) Stock Chart to make your own analysis
- Gemphire Therapeutics Inc (GEMP) Latest news and press-releases to stay up to date.
Does Gemphire Therapeutics Inc (GEMP) stock pay dividends?
GEMP does not pay a dividend.
What is the Price/Earnings (PE) ratio of Gemphire Therapeutics Inc (GEMP)?
Gemphire Therapeutics Inc (GEMP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
GEMP Technical Analysis
GEMP Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to GEMP. GEMP has a bad profitability rating. Also its financial health evaluation is rather negative.
GEMP Financial Highlights
Over the last trailing twelve months GEMP reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS increased by 53.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -674.17% | ||
| ROE | N/A | ||
| Debt/Equity | -6.24 |